The role of spinal cord extrasynaptic α <sub>5</sub> GABA <sub>A</sub> receptors in chronic pain
Rodolfo Delgado‐Lezama, Mariana Bravo‐Hernández, Úrzula Franco‐Enzástiga, Yarim Elideth De la Luz-Cuellar, Nara S. Alvarado‐Cervantes, Guadalupe Raya‐Tafolla, Luis A. Martínez‐Zaldivar, Alberto Vargas‐Parada, Erick J. Rodríguez‐Palma, Guadalupe C. Vidal‐Cantú, Crystell Guadalupe Guzmán‐Priego, Jorge E. Torres‐López, Janet Murbartián, Ricardo Felix, Vinicio Granados‐Soto
Abstract
Chronic pain is an incapacitating condition that affects a large population worldwide. Until now, there is no drug treatment to relieve it. The impairment of GABAergic inhibition mediated by GABAA receptors (GABAAR) is considered a relevant factor in mediating chronic pain. Even though both synaptic and extrasynaptic GABAA inhibition are present in neurons that process nociceptive information, the latter is not considered relevant as a target for the development of pain treatments. In particular, the extrasynaptic α5GABAARs are expressed in laminae I-II of the spinal cord neurons, sensory neurons, and motoneurons. In this review, we discuss evidence showing that blockade of the extrasynaptic α5GABAARs reduces mechanical allodynia in various models of chronic pain and restores the associated loss of rate-dependent depression of the Hoffmann reflex. Furthermore, in healthy animals, extrasynaptic α5GABAAR blockade induces both allodynia and hyperalgesia. These results indicate that this receptor may have an antinociceptive and pronociceptive role in healthy and chronic pain-affected animals, respectively. We propose a hypothesis to explain the relevant role of the extrasynaptic α5GABAARs in the processing of nociceptive information. The data discussed here strongly suggest that this receptor could be a valid pharmacological target to treat chronic pain states.